Il y a eu 50 transactions d'initiés récentes enregistrées pour Plus Therapeutics, Inc. (PSTV), dont 48 achats et 0 ventes. Le total des achats d'initiés s'élève à $3.16M et le total des ventes d'initiés à RSU Award.
Les initiés notables ayant une activité récente comprennent Hedrick Marc H, Sims Andrew John Hugh Macintyre, Andrews Ronald Asbury. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — PSTV
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-04-01 |
Hedrick Marc H |
Chief Executive Officer |
Exercice d'Options |
159,681 |
- |
- |
499,468 |
| 2026-04-01 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
Exercice d'Options |
38,323 |
- |
- |
144,784 |
| 2026-03-20 |
Andrews Ronald Asbury |
Director |
Inconnu |
- |
- |
- |
- |
| 2026-02-25 |
Hedrick Marc H |
Chief Executive Officer |
Attribution de RSU |
2,419,582 |
$0.28 |
$677.48K |
2,419,582 |
| 2026-02-25 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
Attribution de RSU |
349,541 |
$0.28 |
$97.87K |
349,541 |
| 2026-01-01 |
Hedrick Marc H |
Chief Executive Officer |
Exercice d'Options |
159,681 |
- |
- |
339,787 |
| 2026-01-01 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
Exercice d'Options |
38,323 |
- |
- |
106,461 |
| 2025-11-04 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
Achat Informatif |
20,000 |
$0.51 |
$10.2K |
68,138 |
| 2025-10-01 |
Hedrick Marc H |
Chief Executive Officer |
Exercice d'Options |
159,681 |
- |
- |
180,106 |
| 2025-10-01 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
Exercice d'Options |
38,323 |
- |
- |
48,138 |
| 2025-08-22 |
Lenk Robert P |
Director |
Achat Informatif |
110,000 |
$0.49 |
$53.78K |
139,327 |
| 2025-08-13 |
Hedrick Marc H |
Chief Executive Officer |
Attribution de RSU |
1,916,168 |
- |
- |
1,916,168 |
| 2025-08-13 |
Hawkins Richard J |
Director |
Attribution de RSU |
397,794 |
$0.57 |
$228.49K |
397,794 |
| 2025-08-13 |
Lenk Robert P |
Director |
Attribution de RSU |
297,794 |
$0.57 |
$171.05K |
297,794 |
| 2025-08-13 |
Guse Kyle |
Director |
Attribution de RSU |
40,000 |
$0.57 |
$22.98K |
40,000 |
| 2025-08-13 |
Van Es-johansson An |
Director |
Attribution de RSU |
297,794 |
$0.57 |
$171.05K |
297,794 |
| 2025-08-13 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
Attribution de RSU |
459,878 |
- |
- |
459,878 |
| 2025-08-13 |
Clowes Howard |
Director |
Attribution de RSU |
297,794 |
$0.57 |
$171.05K |
297,794 |
| 2025-04-18 |
Guse Kyle |
Director |
Inconnu |
- |
- |
- |
- |
| 2025-02-18 |
Hedrick Marc H |
Chief Executive Officer |
Attribution de RSU |
400,489 |
$1.18 |
$472.58K |
400,489 |
| 2025-02-18 |
Hawkins Richard J |
Director |
Attribution de RSU |
40,122 |
$1.18 |
$47.34K |
40,122 |
| 2025-02-18 |
Lenk Robert P |
Director |
Attribution de RSU |
40,122 |
$1.18 |
$47.34K |
40,122 |
| 2025-02-18 |
Petersen Greg |
Director |
Attribution de RSU |
40,122 |
$1.18 |
$47.34K |
40,122 |
| 2025-02-18 |
Van Es-johansson An |
Director |
Attribution de RSU |
40,122 |
$1.18 |
$47.34K |
40,122 |
| 2025-02-18 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
Attribution de RSU |
60,020 |
$1.18 |
$70.82K |
60,020 |
| 2025-02-18 |
Clowes Howard |
Director |
Attribution de RSU |
40,122 |
$1.18 |
$47.34K |
40,122 |
| 2024-09-13 |
Hawkins Richard J |
Director |
Achat Informatif |
4,000 |
$1.50 |
$6K |
15,188 |
| 2024-09-12 |
Hawkins Richard J |
Director |
Achat Informatif |
6,285 |
$1.35 |
$8.51K |
11,188 |
| 2024-09-11 |
Hedrick Marc H |
Chief Executive Officer |
Attribution de RSU |
197,595 |
$1.26 |
$248.97K |
197,595 |
| 2024-09-11 |
Hawkins Richard J |
Director |
Attribution de RSU |
3,650 |
$1.26 |
$4.6K |
3,650 |
| 2024-09-11 |
Lenk Robert P |
Director |
Attribution de RSU |
3,650 |
$1.26 |
$4.6K |
3,650 |
| 2024-09-11 |
Petersen Greg |
Director |
Attribution de RSU |
3,650 |
$1.26 |
$4.6K |
3,650 |
| 2024-09-11 |
Van Es-johansson An |
Director |
Attribution de RSU |
3,650 |
$1.26 |
$4.6K |
3,650 |
| 2024-09-11 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
Attribution de RSU |
46,074 |
$1.26 |
$58.05K |
46,074 |
| 2024-09-11 |
Clowes Howard |
Director |
Attribution de RSU |
3,650 |
$1.26 |
$4.6K |
3,650 |
| 2024-09-11 |
Petersen Greg |
Director |
Achat Informatif |
12,500 |
$1.35 |
$16.88K |
48,921 |
| 2024-09-11 |
Clowes Howard |
Director |
Achat Informatif |
5,000 |
$1.34 |
$6.68K |
26,497 |
| 2024-09-10 |
Hedrick Marc H |
Chief Executive Officer |
Achat Informatif |
8,000 |
$1.23 |
$9.84K |
20,425 |
| 2024-09-10 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
Achat Informatif |
4,098 |
$1.27 |
$5.2K |
9,815 |
| 2024-05-08 |
Hedrick Marc H |
Chief Executive Officer |
Achat Informatif |
12,255 |
$2.04 |
$25K |
12,425 |
| 2024-05-08 |
Hawkins Richard J |
Director |
Achat Informatif |
4,902 |
$2.04 |
$10K |
4,903 |
| 2024-05-08 |
Lenk Robert P |
Director |
Attribution de RSU |
8,334 |
$1.79 |
$14.92K |
8,334 |
| 2024-05-08 |
Petersen Greg |
Director |
Attribution de RSU |
24,510 |
$1.79 |
$43.87K |
24,510 |
| 2024-05-08 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
Achat Informatif |
4,902 |
$2.04 |
$10K |
5,717 |
| 2024-05-08 |
Clowes Howard |
Director |
Attribution de RSU |
19,608 |
$1.79 |
$35.1K |
19,608 |
| 2024-02-22 |
Hedrick Marc H |
Chief Executive Officer |
Attribution de RSU |
94,012 |
$2.03 |
$190.84K |
94,012 |
| 2024-02-22 |
Hawkins Richard J |
Director |
Attribution de RSU |
2,250 |
$2.03 |
$4.57K |
2,250 |
| 2024-02-22 |
Lenk Robert P |
Director |
Attribution de RSU |
2,250 |
$2.03 |
$4.57K |
2,250 |
| 2024-02-22 |
Lafrance Norman D. |
Chief Medical Officer |
Attribution de RSU |
24,073 |
$2.03 |
$48.87K |
24,073 |
| 2024-02-22 |
Petersen Greg |
Director |
Attribution de RSU |
2,250 |
$2.03 |
$4.57K |
2,250 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
